RETN and breast cancer: The results showed that application of PD98059 largely reduced the migration ability of MDA-MB-231 cells after co-culture with R-ADSCs compared with the group without PD98059 treatment (Fig. 4C), suggesting the participation of ERK pathway in breast cancer cell malignancy induced by resistin-stimulated ADSCs.